Effects of morphine and methadone treatment on mRNA expression of Gα(i) subunits in rat brains

Pharmacological Reports

Volumn 62, Issue 6, 2010, Pages 1197-1203

  Zelek Molik, Agnieszka ^a   Taracha, Ewa ^b   Nawrat, Dominika ^a   Bielawski, Adam ^a   Lehner, Małgorzata ^b   Płaźnik, Adam ^b   Nalepa, Irena ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

^b INSTITUTE OF PSYCHIATRY AND NEUROLOGY   (Poland)

Author keywords

G protein subunits; Methadone; Morphine; MRNA; Nucleus accumbens; Rat brain

Indexed keywords

INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN 1; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN 2; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN 3; MESSENGER RNA; METHADONE; MORPHINE SULFATE; OPIATE AGONIST; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; GENE EXPRESSION; LOCOMOTION; LONG TERM CARE; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; NUCLEUS ACCUMBENS; PROTEIN LOCALIZATION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SEQUENCE;

EID: 79551489617     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: 10.1016/S1734-1140(10)70382-0     Document Type: Article

References (20)

1. Borgland SL, Connor M, Osborne PB, Furness JB, Christie MJ: Opioid agonists have different efficacy profiles for G protein activation, rapid desensitization, and endocytosis of mu-opioid receptors. J Biol Chem, 2003, 278,18776-18784.
2. αi3. J Neurochem, 2000, 74,1068-1078.
3. Kaewsuk S, Hutamekalin P, Ketterman AJ, Khotchabhakdi N, Govitrapong P, Casalotti SO: Morphine induces short-lived changes in G-protein gene expression in rat prefrontal cortex. Eur J Pharmacol 2001, 411, 11-16.
4. Kitanaka N, Kitanaka J, Hall FS, Tatsuta T, Morita Y, Takemura M, Wang XB, Uhl GR: Alterations in the levels of heterotrimeric G protein subunits induced by psychostimulants, opiates, barbiturates, and ethanol: Implications for drug dependence, tolerance, and withdrawal. Synapse, 2008, 62, 689-699.
5. Kreek MJ: Methadone-related opioid agonist pharmacotherapy for heroin addiction. History, recent molecular and neurochemical research and future in mainstream medicine. Ann NY Acad Sci, 2000, 909, 186-216.
6. McLeman ER, Warsh JJ, Ang L, Li PP, Kalasinsky KS, Ross BM, Tong J et al.: The human nucleus accumbens is highly susceptible to G protein down-regulation by methamphetamine and heroin. J Neurochem, 2000, 74, 2120-2126.
7. Nalepa I, Zelek-Molik A, Bielawski A, Roman A, Vetulani J: Does the presence of morphine counteract adaptive changes in expression of G-protein α subunits mRNA induced by chronic morphine treatment? Pharmacol Rep, 2007, 59, 34-45.
8. Nestler EJ, Aghajanian GK: Molecular and cellular basis of addiction. Science, 1997, 278, 58-63.
9. Paxinos G, Watson C: The Rat Brain in Stereotaxic Coordinates. 4th edn, Academic Press, San Diego, 1998.
10. i3 levels in nucleus accumbens. Neuropsychopharmacology, 2008, 33, 2735-2746.
11. Przewlocki R: Opioid abuse and brain gene expression. Eur J Pharmacol, 2004, 500, 331-349.
12. o proteins in nucleus accumbens reduces both cocaine and heroin reinforcement. J Neurosci, 1994, 14, 6239-6247.
13. Taracha E, Chrapusta SJ, Lehner M, Skórzewska A, Maciejak P, Szyndler J, Płaźnik A: Morphine and methadone pre-exposures differently modify brain regional Fos protein expression and locomotor activity responses to morphine challenge in the rat. Drug Alcohol Depend, 2008, 97, 21-32.
14. Taracha E, Chrapusta SJ, Lehner M, Skórzewska A, Płaźnik A: Methadone is substantially less effective than morphine in modifying locomotor and brain Fos responses to subsequent methadone challenge in rats. Prog Neuropsychopharmacol Biol Psychiatry, 2009, 33, 1032-1039.
15. Terwilliger RZ, Beitner-Johnson D, Sevarino KA, Crain SM, Nestler EJ: A general role for adaptations in G-proteins and the cyclic AMP system in mediating the chronic actions of morphine and cocaine on neuronal function. Brain Res, 1991, 548, 100-110.
16. Trescot AM, Datta S, Lee M, Hansen H: Opioid pharmacology. Pain Physician, 2008, 11, 133-153.
17. Tso PH, Wong YH. Molecular basis of opioid dependence: role of signal regulation by G-proteins. Clin Exp Pharmacol Physiol, 2003, 30, 307-316.
18. i/o-coupled receptors. Pharmacol Ther, 2005, 106, 405-421.
19. Wettschureck N, Offermanns S: Mammalian G proteins and their cell type specific functions. Physiol Rev, 2005, 85, 1159-1204.
20. Williams JT, Christie MJ, Manzoni O: Cellular and synaptic adaptations mediating opioid dependence. Physiol Rev, 2001, 81, 299-343.